IN2012DN01273A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN01273A IN2012DN01273A IN1273DEN2012A IN2012DN01273A IN 2012DN01273 A IN2012DN01273 A IN 2012DN01273A IN 1273DEN2012 A IN1273DEN2012 A IN 1273DEN2012A IN 2012DN01273 A IN2012DN01273 A IN 2012DN01273A
- Authority
- IN
- India
- Prior art keywords
- compound
- formula
- disease
- treating
- pharmaceutically acceptable
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000002875 cyclin dependent kinase inhibitor Substances 0.000 abstract 1
- 229940043378 cyclin-dependent kinase inhibitor Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27593809P | 2009-09-04 | 2009-09-04 | |
| US28496209P | 2009-12-28 | 2009-12-28 | |
| PCT/EP2010/062881 WO2011026904A1 (en) | 2009-09-04 | 2010-09-02 | Pyrazinylpyridines useful for the treatment of proliferative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN01273A true IN2012DN01273A (enrdf_load_stackoverflow) | 2015-05-15 |
Family
ID=43480986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1273DEN2012 IN2012DN01273A (enrdf_load_stackoverflow) | 2009-09-04 | 2010-09-02 |
Country Status (10)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8415381B2 (en) * | 2009-07-30 | 2013-04-09 | Novartis Ag | Heteroaryl compounds and their uses |
| CN103339110A (zh) * | 2011-01-28 | 2013-10-02 | 诺瓦提斯公司 | 作为cdk9抑制剂的取代的杂-联芳基化合物及其用途 |
| WO2012101064A1 (en) * | 2011-01-28 | 2012-08-02 | Novartis Ag | N-acyl pyrimidine biaryl compounds as protein kinase inhibitors |
| WO2014106606A1 (en) * | 2013-01-05 | 2014-07-10 | F. Hoffmann-La Roche Ag | Nove phenyl/pyridine series substitued by hydroxyethylamino for the treatment of cancer |
| HK1223927A1 (en) | 2013-09-12 | 2017-08-11 | Sumitomo Chemical Company, Limited | Nitrogen-containing saturated heterocyclic compound |
| JO3589B1 (ar) | 2014-08-06 | 2020-07-05 | Novartis Ag | مثبطات كيناز البروتين c وطرق استخداماتها |
| RU2019111887A (ru) | 2016-10-20 | 2020-11-20 | Пфайзер Инк. | Антипролиферативные средства для лечения лаг |
| WO2020016579A2 (en) | 2018-07-17 | 2020-01-23 | Gtn Ltd | Machine learning based methods of analysing drug-like molecules |
| US20230102081A1 (en) * | 2019-12-09 | 2023-03-30 | Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Compound as cyclin-dependent kinase 9 inhibitor and use thereof |
| GB202013419D0 (en) | 2020-08-27 | 2020-10-14 | Kuano Ltd | Transition state 2020 |
| WO2022247796A1 (zh) * | 2021-05-24 | 2022-12-01 | 石药集团中奇制药技术（石家庄）有限公司 | 周期蛋白依赖性激酶9抑制剂的用途 |
| WO2022247785A1 (zh) * | 2021-05-24 | 2022-12-01 | 石药集团中奇制药技术（石家庄）有限公司 | 一种周期蛋白依赖性激酶9抑制剂的用途 |
| WO2022257965A1 (zh) * | 2021-06-09 | 2022-12-15 | 石药集团中奇制药技术（石家庄）有限公司 | 固体形式的周期蛋白依赖性激酶9抑制剂及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT72878B (en) | 1980-04-24 | 1983-03-29 | Merck & Co Inc | Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents |
| EP1330452B1 (en) * | 2000-09-20 | 2008-11-26 | Ortho-McNeil Pharmaceutical, Inc. | Pyrazine derivatives as modulators of tyrosine kinases |
| EP1631260A2 (en) | 2003-02-28 | 2006-03-08 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| WO2008079933A2 (en) * | 2006-12-22 | 2008-07-03 | Novartis Ag | Heteroaryl-heteroaryl compounds as cdk inhibitors for the treatment of cancer, inflammation and viral infections |
-
2010
- 2010-09-02 WO PCT/EP2010/062881 patent/WO2011026904A1/en active Application Filing
- 2010-09-02 CN CN2010800392830A patent/CN102482265A/zh active Pending
- 2010-09-02 BR BR112012004836A patent/BR112012004836A2/pt not_active IP Right Cessation
- 2010-09-02 AU AU2010291199A patent/AU2010291199A1/en not_active Abandoned
- 2010-09-02 KR KR1020127008621A patent/KR20120076352A/ko not_active Withdrawn
- 2010-09-02 IN IN1273DEN2012 patent/IN2012DN01273A/en unknown
- 2010-09-02 MX MX2012002758A patent/MX2012002758A/es not_active Application Discontinuation
- 2010-09-02 CA CA2772265A patent/CA2772265A1/en not_active Abandoned
- 2010-09-02 US US13/393,457 patent/US20120165306A1/en not_active Abandoned
- 2010-09-02 EP EP10748097A patent/EP2473505A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011026904A1 (en) | 2011-03-10 |
| CN102482265A (zh) | 2012-05-30 |
| MX2012002758A (es) | 2012-04-19 |
| CA2772265A1 (en) | 2011-03-10 |
| KR20120076352A (ko) | 2012-07-09 |
| EP2473505A1 (en) | 2012-07-11 |
| US20120165306A1 (en) | 2012-06-28 |
| BR112012004836A2 (pt) | 2019-09-24 |
| AU2010291199A1 (en) | 2012-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN01273A (enrdf_load_stackoverflow) | ||
| MX2012002752A (es) | Compuestos de heteroarilo como inhibidores de cinasa. | |
| MX2012002761A (es) | Bipiridinas utiles para el tratamiento de enfermedades proliferativas. | |
| WO2011123946A8 (en) | Kinase inhibitors and method of treating cancer with same | |
| UA105794C2 (uk) | 1,3-ДИЗАМІЩЕНІ ПОХІДНІ ІМІДАЗОЛІДИН-2-ОНУ ЯК ІНГІБІТОРИ Cyp17 | |
| TN2011000400A1 (en) | Inhibitors of beta-secretase | |
| WO2010151710A3 (en) | Substituted heterocyclic compounds as kinases inhibitors and method of use thereof | |
| MX2011009796A (es) | Inhibidores de la cinasa pi3. | |
| TN2011000293A1 (en) | Protein kinase inhibitors | |
| AU2012214029A8 (en) | Rorgammat inhibitors | |
| WO2010135524A8 (en) | Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases | |
| MX2011011854A (es) | Dihidropirimidinonas para uso como inhibidores de la bace2. | |
| WO2012068096A3 (en) | Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture | |
| WO2012068106A3 (en) | Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture | |
| TN2012000152A1 (en) | Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes | |
| MX2012015098A (es) | Compuestos heterociclicos fusionados como inhibidores de fosfodiesterasas (pdes). | |
| GEP20125708B (en) | Hydroxamate-based inhibitors of deacetylases b | |
| MY170922A (en) | Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives | |
| MX2010008460A (es) | Derivado de tiazol y su uso como inhibidor de proteina-1 de adhesion vascular. | |
| MX2013002851A (es) | Inhibidores de tonum pectinacetilesterasa y metodos de su uso. | |
| UA105527C2 (uk) | Сполука-інгібітор матриптази для лікування раку | |
| MX2010008226A (es) | Derivados de difluorobifenilamida para el tratamiento de hipertension ocular. | |
| UA101091C2 (ru) | Способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой | |
| EA201200868A1 (ru) | Ингибиторы диацилглицеролацилтрансферазы | |
| WO2010123545A3 (en) | Angiogenesis inhibitors |